ATHENS, Ohio--(BUSINESS WIRE)--Diagnostic HYBRIDS announces the release of its D3 DFA Varicella-zoster Virus Identification Kit for the qualitative identification of Varicella-zoster virus (VZV) in cell culture by immunofluorescence. The kit is for in vitro diagnostic use and utilizes a blend of proprietary monoclonal antibodies directed against two specific VZV proteins. When combined with the patented Diagnostic HYBRIDS H&V-MixTM Mixed FreshCellsTM culture system, results can be obtained in as little as 20 hours from all specimen types.
